Harrow (HROW) Other Non Operating Income (2010 - 2025)
Harrow (HROW) posted Other Non Operating Income of -$7.8 million for Q3 2025, down 129066.67% on a QoQ basis from -$6000.0 in Q2 2025, and down 193850.0% year-over-year from N/an in Q3 2024.
Powered by 
Analysis
Harrow (HROW) Other Non Operating Income (2010 - 2025) Analysis & Trends
Harrow has reported Other Non Operating Income for 11 years, with the latest figure at -$7.8 million in Q3 2025.
- On a quarterly basis, Other Non Operating Income fell 193850.0% year-over-year to -$7.8 million in Q3 2025; TTM through Jun 2026 was -$7.8 million, a 3474.19% decrease from a year earlier, with the FY2025 full-year figure at -$7.8 million, down 4089.19% from the prior year.
- Other Non Operating Income was -$7.8 million for Q3 2025 at Harrow, down from -$6000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $46000.0 in Q2 2024, with the low at -$7.8 million in Q3 2025.
- Average Other Non Operating Income over 4 years is -$1.5 million, with a median of -$186500.0 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income jumped 125.84% in 2024, then tumbled 193850.0% in 2025.
- Over 4 years, Other Non Operating Income stood at -$756000.0 in 2021, then jumped by 74.21% to -$195000.0 in 2023, then slumped by 33.85% to -$261000.0 in 2024, then sank by 2869.35% to -$7.8 million in 2025.
- The last three Other Non Operating Income figures came in at -$7.8 million (Q3 2025), -$6000.0 (Q2 2025), and -$261000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Harrow | 1.42 Bn | 1.33 Bn | 50.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -7.75 Mn |
| Jun 30, 2025 | -6,000.00 |
| Dec 31, 2024 | -261,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Sep 30, 2023 | -195,000.00 |
| Jun 30, 2023 | -178,000.00 |
| Mar 31, 2023 | -5.47 Mn |
| Jun 30, 2021 | -756,000.00 |
| Dec 31, 2020 | -97,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 19,000.00 |
| Mar 31, 2019 | 630,000.00 |
| Dec 31, 2018 | 358,000.00 |
| Jun 30, 2018 | -255,000.00 |
| Dec 31, 2017 | -6.61 Mn |
| Sep 30, 2017 | -884,000.00 |
| Jun 30, 2017 | 5.73 Mn |
| Sep 30, 2016 | 1.49 Mn |